ArticlemedRxiv : the preprint server for health sciences2023

Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.

Bachisio Ziccheddu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.